Pharmagreen Biotech Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q4 2020 to Q4 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Pharmagreen Biotech Inc. quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q4 2020 to Q4 2022.
- Pharmagreen Biotech Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending December 31, 2022 was -$51.5K, a 417% decline year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)